Glipizide
Glipizide is a pharmaceutical drug with 20 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 18 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
2
Mid Stage
15
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
18 of 18 finished
0.0%
0 ended early
1
trials recruiting
20
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer
Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease - Changing Glucose Management
A Study of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)
Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128)
Clinical Trials (20)
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer
Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease - Changing Glucose Management
A Study of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)
Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128)
Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1)
Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1)
Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052)
Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes
Effect of Exenatide on Liver and Heart Fat and Inflammation
An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED)
Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients
Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes Mellitus
Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Diabetics
Efficacy of Acarbose on Intestinal Microbiome and Incretins of Type 2 Diabetes
Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) Patients
Study on the Prognosis and Effect of Anti-diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery Disease
Cytochrome P450 2C19 Variant is Related to Pharmacokinetics of Glipizide Extended Release Tablet in Chinese Subjects
Insulin Glargine in Type 2 Diabetic Patients
Combination of Sulfonylureas and Insulin Glargine Outpatient Therapy for Unstable Diabetes and Impending DKA
All 20 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 20